Introduction
For over 25 years [ l ] it has been realized that a considerable phospholipid asymmetry exists across the bilayer of the biological membrane, particularly the plasma membrane, and this asymmetry plays a major role in cell function [2-61. T h e asymmetry is best illustrated by the Abbreviations used: PC, phosphatidylcholine; PA, phosphatidic acid; PS, phosphatidylserine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PLA2, phospholipase A,; FABP, fatty acid binding protein; DAUDA, 1 1-(dansy1arnino)undecanoic acid; sPLA2, secreted phospholipase A,; PLD, phospholipase D; CL, cardiolipin.
fact that the external monolayer of the mammalian cell is made u p almost exclusively of neutral zwitterionic phospholipids such as phosphatidylcholine (PC) and sphingomyelin together with some phosphatidylethanolamine. In contrast, the monolayer facing the cytoplasm of the cell contains anionic phospholipids as a major component together with the majority of the phosphatidylethanolamine. Intracellular anionic phospholipids include phosphatidylserine (PS), phosphatidylinositol (PI) and its phosphorylated derivatives, phosphatidylglycerol (PG) and cardiolipin (CL) . A number of specific physiological roles have emerged for these anionic Volume 26 phospholipids that affect intracellular functions and, in the case of PS, the interaction of the cell with extracellular proteins. These biological functions are normally initiated by the binding of specific proteins to the phospholipid interface resulting in a conformational change linked to protein activation and the biological response.
The overall phenomenon can be represented as follows: P +phospholipid,, % P* + L% P*L +biological response where P is a protein molecule, phospholipid(,, is the phospholipid interface, P* is the activated protein bound to the interface and P*L represents specific binding of a ligand linked to the biological response such as catalysis.
The interaction of proteins with anionic phospholipids as part of protein function can be broadly divided into two categories.
Interfacial binding
Interfacial binding (P P*) is relatively nonspecific and requires the presence of a significant mol% (normally > 5 mol%) of the anionic phospholipid at the membrane surface. The presence of the anionic phospholipid will facilitate the binding of the protein by initial electrostatic interactions. However, subsequent penetration of parts of the protein into the bilayer may occur as a result of perturbation of the membrane surface. Such perturbations of the interface will be facilitated by the presence of the anionic phospholipids [7] . There is considerable interest in the role of anionic phospholipids in the interfacial binding and activation of proteins. The participation of anionic phospholipids in membrane-protein interactions has been reviewed in detail [3-7,10,11] with a particular focus on the ability of certain lipids to form non-lamellar phases [7] . Although such non-lamellar phases have yet to be observed in biological, as opposed to artificial membranes, it may be the propensity of such lipids to form such structures that may have critical effects on the quality of the interface and thus be the basis of membrane perturbation.
Specific binding
The driving force for an inverted phase is the effective shape or molecular geometry of the phospholipid. A smaller head group relative to the hydrophobic part of the molecule would provide the crucial shape to form inverted nonlamellar phases. Anionic phospholipids with relatively small headgroups, such as PS, phosphatidic acid (PA) and CL, together with calcium provide the necessary geometry for non-lamellar phases and a resultant perturbation of the interface. Following initial electrostatic interactions between the anionic interface and cationic regions of the protein surface, a number of steps linked to conformational changes in the protein may occur.
Interfacial events can involve membrane penetration by the protein, phospholipid extraction by the protein to specific binding sites or a combination of both. Membrane penetration may involve amphipathic helices, surface tryptophan residues, amino acids modified with acyl or prenyl groups, or effects linked to a high local concentration of H + associated with negatively charged phospholipid headgroups [lo]. Phospholipid extraction and protein binding normally involves the presence of a non-polar cavity on the interfacial surface of the protein. Kinnunen [7] has argued that such phospholipid binding may involve a single acyl chain, the phospholipid thus acting as a bridge between protein and bilayer. The phenomenon of protein translocation to the interface can play a major regulatory role in protein function. Important enzymes that are regulated by translocation to the phospholipid surface include cytosolic phospholipase A2 (PLA2) [ 121, protein kinase C [13] and CTP phosphocholine cytidyl transferase [ 141.
Specific anionic phospholipids and their role in the regulation of cell functions PS exposure, blood coagulation and apoptosis
The classic physiological example of the bulk exposure of an ionic phospholipid on the external surface of the cell is that of PS. This phospholipid is normally located exclusively on the inner monolayer surface of the plasma membrane and other internal cell membranes. The PS is actively transported from the outer to the inner leaflet of the plasma membrane by the aminophospholipid translocase [3, 4] . The exposure of PS to the external cell surface is a characteristic of platelet activation [6] and apoptosis [15] . This PS-containing interface is recognized by proteins involved both in blood clotting and macrophage phagocytosis. In addition annexin V, a calcium and phospholipid binding protein with a high affinity for PS, was first identified as a vascular anti-coagulant protein that bound with high affinity to such surfaces and inhibited blood coagulation [ 16,171. Labelled annexin V now provides a standard marker for PS exposure in apoptotic cells [18] .
PA exposure and the regulation of human (group /la) secreted PLA2
Perhaps one of the most intriguing aspects of externalized anionic phospholipids is their possible role in promoting the action of the human (Group IIa) secreted PLA2 (human sPLA2). The human enzyme was first identified at high concentration in the synovial fluid of patients with rheumatoid arthritis and is now known to be associated with a wide variety of inflammatory disorders where its concentration in extracellular fluids such as serum may rise in excess of 100-fold [ 191. Despite its overall structural similarity to the destructive venom PLA2s, we and others have demonstrated the virtual inability of this highly basic (PI > 10.5) enzyme to hydrolyse zwitterionic PC interfaces seen either in phospholipid vesicles or cell membranes [20] [21] [22] [23] [24] . Therefore the precise molecular mechanism by which this enzyme might become proinflammatory remains elusive especially since elevated levels of the human enzyme in transgenic mice does not appear to be associated with significant inflammatory pathology [ZS] . Indeed the primary role of human sPLA2 is believed to be that of an acute-phase protein involved in the removal of infectious micro-organisms and damaged cells [26] .
The possibility that the enzyme might be capable of attacking the perturbed membrane of normal cells, thus becoming pro-inflammatory, has been considered [27] . The extreme cationic nature of this enzyme and, in particular, the cationic nature of the interfacial surface of the enzyme point toward a dominant role for electrostatic interaction in interfacial binding while the presence of negative charge in the surface monolayer of the plasma membrane should both enhance binding of the enzyme and facilitate hydrolysis [22] .
In a search for natural anionic phospholipids that might promote interfacial binding and hydrolysis of the plasma membrane by recombinant human sPLAz [28] we have investigated the potential role of PA in this process [21] . Not only does the addition of low concentrations of PA to vesicles prepared from PC enhance hydrolysis by human sPLA2 but also pretreatment of pure PC-containing vesicles with phospholipase D (PLD) produce both a time-and dose-dependent increase in hydrolysis [21] .
Of particular interest is the fact that pretreatment of whole cells in suspension with bacterial PLD dramatically enhances their susceptibility to human sPLA2 [21] . This enhanced hydrolysis of cell suspensions can be measured directly using a continuous fluorescence displacement assay [29] in which released longchain fatty acid displaces the fluorescent fatty acid 1 1 -(dansylamino) -undecanoic acid (DAUDA) from liver fatty acid binding protein (FABP) that is present in the medum with a resulting loss in fluorescence. We observe that pretreatment of a cell suspension with bacterial PLD produces a time-and dose-dependent response such that the cell membrane becomes sensitive to hydrolysis by added human sPLA2. Thus, hydrolysis is observed at a concentration as low as 100 nglml of human sPLA2 in the medium whereas, prior to PLD treatment, in excess of 10 pglml of enzyme is often required to detect significant cell hydrolysis under these assay conditions. Blood levels of human sPLA2 in septic shock can be in excess of 1 pglml.
In a separate study (A. D. Postle and S. M.
Wright, personal communication) electrospray ionization mass spectrometry has been used to detect the formation of PA in HL 60 cell suspensions after pretreatment with added bacterial PLD. The spectra before and after treatment with PLD are shown in Figure 1 . Part (b) shows the profile of molecular species of PA in the normal cell while part (a) shows the dramatic increase of PA resulting from PLD treatment, the molecular species reflecting the abundance of the equivalent PC species in untreated cells. This result directly confirms the capacity of Volume 26 externally added PLD to hydrolyse cell surface PC.
If the PA were the preferred substrate for the human sPLA2, then two potential types of pro-inflammatory lipid mediators would be produced, fatty acids including arachidonic acid and lysoPA. It is noteworthy that lysoPA has been observed after pretreatment of micro vesicles with human sPLAz [24] and this recombinant enzyme shows a clear substrate preference for PA [30] . It remains to be established if production of PA in the surface monolayer of intact cells in vivo can provide the necessary activation to initiate an inflammatory response in the presence of inflammatory levels of the human sPLAz. Although there is no indication that PLD is observed extracellularly, an equivalent glycosylphosphatidyl inositol PLD is found in serum [31] and could generate PA on the cell surface.
PG, CL (diphosphatidyl glycerol) and the regulation of liver FABP function
Liver FABP provides another example of a protein that can bind specifically to an anionic phospholipid interface. Liver FABP belongs to a family of small (14 kDa) cytosolic lipid binding proteins that includes FABPs from muscle, intestine and adipose tissue [32, 33] . Although the precise physiological function of these abundant proteins remains obscure a buffering role is likely whereby the binding of the high concentrations of fatty acids associated with these tissues would prevent cellular damage [34]. Of particular interest is a vectorial role of FABPs in the transport and targeting of fatty acids to specific sites within the cell. Such a role has already been highlighted in the case of the intestinal, muscle and adipose proteins [35, 36] where fatty acid transfer to model phospholipid membranes occurs by a collisional interaction. However, no such collisional mechanism was observed in the case of liver FABP and fatty acid transfer involving aqueous diffusion of the ligand was proposed
We have observed that a collisional transfer mechanism is possible with liver FABP under appropriate conditions involving phospholipid vesicles containing specific anionic phospholipids. This collisional event could be detected because on addition of phospholipid vesicles to a highly fluorescent liver FABP/DAUDA complex, there was complete binding to the phospholipid interface and a dramatic fall in fluorescence due to release of the fluorescent ligand, DAUDA, from the FABP (Figure 2 ). On addition of more FABP to this assay (Figure 2) there was complete fluorescence recovery thus confirming that DAUDA was released from the phospholipid vesicle-bound FABP. T h e binding of the FABP to phospholipid vesicles showed phospholipid specificity with DAUDA release being most sensitive to CL and PG (A. E. A. Thumser, J. K. Davis and D. C. Wilton, unpublished work) while no ligand release was seen with PC or PE.
The process was very ionic strengthdependent, demonstrating a major contribution of electrostatic binding, while complete dissociation of DAUDA from FABP required a molar ratio of phospholipid to protein consistent with the protein coating the anionic phospholipid The ability of added of anionic phospholipid vesicles to displace DAUDA from liver FABP A solution of I 0 mg/ml phospholipid in methanol containing a I :4 molar ratio of CL/PC was titrated into a highly fluorescent complex of FABP (8 pg/ml) and DAUDA ( I pM) in I 0 mM HEPES buffer (pH 7.5). After the addition of 80 pg of total phospholipid, there was no fluorescence due to the FABP/DAUDA complex. At this point additional FABP was titrated into the assay with full recovery of FABP/DAUDA fluorescence.
m loo R interface. The binding process could be partially reversed, as judged by a recovery of fluorescence, by the addition of high salt (200mM NaCI) or calcium (5 mM) and reversal was most apparent when the FABP bound to mixed vesicles contained both anionic phospholipid (PG) and PC. Under these conditions maximal reversal (>90%) also required the addition of ethanol suggesting that there were non-polar interactions between the protein and the interface. It would appear that the proportion of non-polar interactions depended on the density of anionic phospholipid in the interface. This type of binding has also been observed in the case of cytochrome c [38] . Overall the phenomenon of interfacial binding of liver FABP and ligand release provides an attractive mechanism for delivery of long-chain fatty acids to the membrane surface within the cell for further metabolism.
In conclusion, anionic phospholipids provide an environment for a wide range of protein interactions that facilitate interfacial binding. The probable underlying feature of these interactions is the propensity of anionic phospholipids to form non-lamellar structures thus perturbing the interface. This perturbation facilitates conformational changes in the protein linked to membrane penetration by the protein or, alternatively, phospholipid removal from the interface into 
